We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Oral Contrast Administered During CT Scans for Diagnosis of Acute Appendicitis Offers Slight Benefit

By HospiMedica International staff writers
Posted on 09 Jun 2010
Patient ingestion of oral contrast provides only a small increase in the accuracy of computed tomography (CT) scans used in the diagnosis of acute appendicitis. More...


Oral contrast is frequently used during CT for the diagnosis of acute appendicitis to help localize the appendix. The study, performed at Pennsylvania (Penn) State Hershey Medical Center (Hershey, PA, USA) included 192 CT exams that were performed with oral contrast and 72 without. The study's findings revealed that the accuracy of CT without oral contrast in diagnosing appendicitis was 93% and CT with oral contrast was 97%,” said Rafel Tappouni, M.D., lead author of the study. "There is no significant difference in the accuracy of CT with versus without oral contrast in diagnosing acute appendicitis,” he said.

The study was presented May 4, 2010, at the American Roentgen Ray Society (ARRS) 2010 annual meeting, held in San Diego, CA, USA.

"At our institution, we stopped using oral contrast on CT of the abdomen and pelvis for the diagnosis of acute appendicitis over a year ago. This was well accepted by our emergency department physicians and has lead to improved work flow and less waiting for both patients and physicians,” noted Dr. Tappouni. "Oral contrast administration delays a CT exam and therefore should be avoided in patients undergoing CT with a suspected diagnosis of acute appendicitis.”

Related Links:
Penn State Hershey Medical Center


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.